On November 2, 2015, Vivione Biosciences Inc. closed the transaction. The company announced that it has issued 1,000,000 series A preferred units for gross proceeds of $1,000,000.
1st Jan change | Capi. | |
---|---|---|
+15.30% | 3.1B | |
+31.41% | 2.06B | |
+8.43% | 1.51B | |
-11.54% | 1.19B | |
+16.20% | 726M | |
+10.61% | 674M | |
+33.50% | 556M | |
-4.17% | 500M | |
+25.78% | 462M |